BPCIA Litigation

Strategic considerations for counsel when litigating a case under the Biologics Price Competition and Innovation Act (BPCIA), which creates an abbreviated pathway to obtain Food and Drug Administration (FDA) approval for medicines that are biosimilar to or interchangeable with a previously approved biologic product.